It is expected that marketing autho

It is expected that marketing authorizations for medical products will be mutually recognized among member countries. Speeding up the process of registration of medical products and might influence the reduction of registration costs and timelines if implemented correctly.
We need to balance conflicts of interest between the pharmaceutical industry and the healthcare system, and each country will have to decide how to do this in its own way
привлечение иностранных инвесторов

Results (English) 1:

It is expected that the marketing authorizations for medical products will be mutually recognized among member countries. Speeding up the process of registration of medical products and might influence the reduction of registration costs and timelines if implemented correctly. We need to balance the conflicts of interest between the pharmaceutical industry and the healthcare system, and each country will have to decide how to do this in its own wayattracting foreign investors

Results (English) 2:

It is expected that marketing authorizations for medical products will be mutually recognized among member countries. Speeding up the Process of registration of Medical products and Might Influence the Reduction of Costs and registration timelines if Implemented correctly.
We need to balance Conflicts of Interest Between the Pharmaceutical Industry and the Healthcare system, and each Country Will have to Decide how to do this in its own way
to attract foreign investors

Results (English) 3:

It is expected that marketing authorizations only for medical products will be mutuаlly recognized among member countries. Speeding up the process of registration of medical products and consensual extension influence the reduction of registration costs and timelines if a WMI interface соrreсtly.
We need to balance conflicts of interest between the successfully raised money industry and the healthcare system,